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Abstract
The emergence of viral respiratory pathogens with pandemic potential, such as severe acute respiratory syndrome
coronavirus (SARS-CoV) and influenza A H5N1, urges the need for deciphering their pathogenesis to develop new
intervention strategies. SARS-CoV infection causes acute lung injury (ALI) that may develop into life-threatening acute
respiratory distress syndrome (ARDS) with advanced age correlating positively with adverse disease outcome. The molecular
pathways, however, that cause virus-induced ALI/ARDS in aged individuals are ill-defined. Here, we show that SARS-CoV-
infected aged macaques develop more severe pathology than young adult animals, even though viral replication levels are
similar. Comprehensive genomic analyses indicate that aged macaques have a stronger host response to virus infection
than young adult macaques, with an increase in differential expression of genes associated with inflammation, with NF-kB
as central player, whereas expression of type I interferon (IFN)-b is reduced. Therapeutic treatment of SARS-CoV-infected
aged macaques with type I IFN reduces pathology and diminishes pro-inflammatory gene expression, including interleukin-
8 (IL-8) levels, without affecting virus replication in the lungs. Thus, ALI in SARS-CoV-infected aged macaques developed as a
result of an exacerbated innate host response. The anti-inflammatory action of type I IFN reveals a potential intervention
strategy for virus-induced ALI.
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Introduction
The zoonotic transmission of severe acute respiratory syndrome
coronavirus (SARS-CoV) caused pneumonic disease in humans
with an overall mortality rate of ,10%. The exact reasons why
some individuals succumbed to the infection while others
remained relatively unaffected have not been clarified. Aging, an
important risk factor in SARS-CoV-associated disease, is associ-
ated with changes in immunity [1,2,3]. Consequently, elderly
individuals are at greater risk of contracting more severe and
longer lasting infections with increased morbidity and mortality,
exemplified by respiratory tract infections caused by influenza A
virus and severe acute respiratory syndrome (SARS) coronavirus
[4,5,6]. The clinical course of SARS-CoV-induced disease follows
a triphasic pattern [5]. The first phase is characterized by fever,
myalgia and other systemic symptoms that are likely caused by the
increase in viral replication and cytolysis. The second phase of the
disease is characterized by a decrease in viral replication that
correlates with the onset of IgG conversion. Interestingly, it is also
in this phase that severe clinical worsening is seen, which can not
be explained by uncontrolled viral replication. It has been
hypothesized that the diffuse alveolar lung damage in this phase
is caused by an over exuberant host response [5,7,8]. The majority
of patients recovers after 1–2 weeks, but up to one-third of the
patients progress to the third phase and develop severe
inflammation of the lung, characterized by acute respiratory
distress syndrome (ARDS) [9]. The clinical course and outcome of
SARS-CoV disease are more favorable in children younger than
12 years of age as compared to adolescents and adults [10,11,12];
elderly patients have a poor prognosis, with mortality rates of up to
,50% [5,6].
For SARS-CoV-associated disease in humans, it has been
hypothesized that seemingly excessive pro-inflammatory respons-
es, illustrated by elevated levels of inflammatory cytokines and
chemokines, mediate immune-pathology resulting in acute lung
injury (ALI) and ARDS [5,13,14,15,16]. Direct support for this
concept, however, is scarce. ALI and ARDS are typified by
inflammation, with increased permeability of the alveolar-capillary
barrier, resulting in pulmonary edema, hypoxia, and accumulation
of polymorphonuclear leukocytes and macrophages. Inflammatory
cytokines, among which IL-1b and IL-8, play a major role in
mediating and amplifying ALI/ARDS [9] and are elevated in
SARS-CoV-infected patients as well [13,14]. In vitro experiments
confirm that SARS-CoV infection induces expression of cyto-
kines/chemokines in a range of cell types [15,17,18]. Moreover,
infection of cynomolgus macaques with SARS-CoV leads to a
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chemokines, resembling the host response seen in human SARS
patients [19]. Nevertheless, the determinants that lead to severe
virus-associated ALI/ARDS and that cause people to succumb to
infection remain largely obscure, restraining development of
appropriate treatments.
As advanced age is a predictor of adverse clinical outcome in
both ARDS and SARS-CoV infections [5,20], we used age as
predisposing factor to study the pathogenesis of SARS-CoV in a
macaque model. By performing comparative analyses of young
adult and aged SARS-CoV-infected macaques regarding pathol-
ogy, virus replication and host response, insight into the
pathogenesis of SARS-CoV is obtained and a potential therapeutic
intervention strategy for virus-induced ALI is revealed.
Results
SARS-CoV causes more severe pathology in aged than in
young adult macaques
To obtain further insights in the pathogenesis of SARS-CoV, six
aged (10–19 years old) and six young adult (3–5 years old)
cynomolgus macaques were infected with SARS-CoV HKU39849
and euthanized four days after infection. Four young adult and
four aged PBS-infected cynomolgus macaques were used as
negative controls. During the 4-day experiment, some of the
SARS-CoV-infected aged animals displayed decreased activity
and mildly labored breathing. All aged infected macaques showed
an increase in body temperature either during the night or during
the day one to two days after infection (Figure 1A). The lungs of
aged macaques showed large (multi)focal pulmonary consolidation
that was severe (,40–60% of affected lung tissue) in two macaques
(Figure 1B and Figure S1). Microscopic examination revealed
typical ALI-associated lesions, similar to what has been seen in
SARS-CoV-infected humans that progress to ARDS [6]. Lesions
involved the alveoli and terminal bronchioli, showing areas with
acute or more advanced phases of diffuse alveolar damage
(Figure 2). Lumina of alveoli were variably filled with protein rich
edema fluid, cellular debris, alveolar macrophages and neutro-
phils, eosinophils, and lymphocytes (Figure 2 and Figure S2A–B).
Moderately thickened alveolar walls were lined by cuboidal
epithelial cells (type 2 pneumocyte hyperplasia; Figure 2 and
Figure S2C). The epithelial origin of these enlarged type 2
pneumocytes with large vacuolated nuclei, prominent nucleoli and
abundant vesicular cytoplasm was confirmed by keratin staining
(Figure S2D). Hyaline membranes and multinucleated giant cells
were occasionally observed in the alveoli (Figure S2E–F). In
contrast, all young adult animals remained free of clinical
symptoms and had no or less extensive pulmonary consolidation
(Figure 1A–C). Hyaline membranes were not observed in SARS-
CoV-infected young adult macaques. A multifocal mild chronic
lymphoplasmacytic tracheo-bronchoadenitis, characterized by
moderate numbers of lymphocytes, plasma cells, macrophages,
less neutrophils and occasional eosinophils in the lamina propria of
the bronchi, focally surrounding and infiltrating the submucosal
glands, was observed in all young adult macaques, but not in aged
macaques (Figure 2). Our data were confirmed by retrospective
analysis of earlier experiments in which aged animals were used
[19,21,22,23]. Overall, aged macaques develop more severe
SARS-CoV-associated ALI than young adults.
The level of viral replication in aged and young adult
macaques is similar
Because viral replication is important for disease pathogenesis,
we determined virus titers in aged and young adult animals. Virus
excretion in the throat (Figure 3A) and nose (Figure 3B) of aged
and young adult macaques at days 2 and 4 post infection was not
significantly different. Moreover, no significant difference in
quantity of SARS-CoV mRNA in the lungs of young adult and
aged animals was observed (Figure 3C). Differences in the nature
and percentage of SARS-CoV-infected cells in the lungs of aged
and young adult macaques were not seen either (Figure 3D).
Apparently, augmented pathology in aged macaques cannot be
rationalized by increased viral replication.
The host response to SARS-CoV infection is stronger in
aged than in young adult macaques
To understand why SARS-CoV-infection in aged macaques
results in more severe pathology than in young adult macaques, we
determined global gene expression profiles by analyzing total RNA
isolated from the lungs using microarray analysis. Hierarchical
clustering methods were used to order gene transcripts and
individual aged and young adult animals to identify groups of
animals with similar expression patterns. These data were plotted
as a heat map in which each entry represents a gene expression
value (Figure 4). As expected in an animal experiment with
outbred animals, the inter-animal variation was relatively high
(Figure S3). There were two major roots to the hierarchical
dendogram, with one root containing the PBS-infected control
animals, and the second root containing the SARS-CoV-infected
animals. The root of the PBS-infected control animals was divided
in two minor roots, clustering young adults together and aged
animals as a group. These data suggest that the baseline expression
patterns are different in young adult and aged macaques. The root
of the SARS-CoV-infected animals was also divided in two minor
roots, largely clustering young adult animals together and
grouping aged infected macaques. The hierarchical clustering
heat map suggests that both age and SARS-CoV infection are key
factors involved in determining transcription of cellular genes.
To determine whether aged and young adult animals respond
differently to SARS-CoV-infection, their gene expression profiles
Author Summary
Severe acute respiratory syndrome coronavirus (SARS-CoV)
infection causes acute lung injury that may develop into
the life-threatening acute respiratory distress syndrome
(ARDS) in mostly elderly individuals. Although SARS-CoV
infection can be fatal, most patients recover, suggesting
that protective host responses are operational to combat
the viral infection. Therefore, we used age as predisposing
factor to obtain insight into the pathogenesis of SARS-CoV.
In this study, we show that SARS-CoV-infected aged
macaques developed significantly more pathology than
young adult animals, which could not be contributed to
differences in viral replication. Using comparative micro-
array analyses, it was shown that although the nature of
the host response to SARS-CoV infection was similar in
aged and young adult macaques, the severity was
significantly different, with aged macaques displaying an
increase in differential expression of genes associated with
inflammation. Interestingly, type I IFN-b mRNA levels
correlated negatively with gross pathology. Therapeutic
treatment of aged macaques with type I IFN reduced
pathology without affecting virus replication. However,
pro-inflammatory gene expression was significantly dimin-
ished. Thus, modulation of the host response by type I IFNs
provides a promising outlook for novel intervention
strategies.
Host Response to SARS-CoV
PLoS Pathogens | www.plospathogens.org 2 February 2010 | Volume 6 | Issue 2 | e1000756Figure 1. Aged macaques are more prone to develop SARS-CoV-associated disease than young adults. (A) Fluctuations in body
temperatures in four young adult and four aged SARS-CoV-infected macaques measured by transponders in the peritoneal cavity. Temperatures are
shown from day six prior to infection until four days post infection. The arrow indicates day zero when animals were infected. Grey horizontal lines
mark the average range of temperature fluctuations prior to infection. (B) Macroscopic appearance of (consolidated) lung tissue of young adult and
aged SARS-CoV infected macaques at day 4 post infection. Lesions are arrowed. (C) Gross pathology scores of aged and young adult macaque groups
were determined after necropsy and averaged (6standard error of the mean (s.e.m.)).
doi:10.1371/journal.ppat.1000756.g001
Figure 2. Histology of lungs from SARS-CoV-infected aged macaques. Lesions in lungs of PBS-infected (left panel) and SARS-CoV infected
young adult (middle panel) and aged (right panel) macaques showing diffuse alveolar damage, characterized by disruption of alveolar walls causing
edema and type II pneumocyte hyperplasia with influx of inflammatory cells in the alveoli and bronchioles. In the trachea, a multifocal mild chronic
lymphoplasmacytic tracheobronchoadenitis was observed in young adult macaques.
doi:10.1371/journal.ppat.1000756.g002
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young adult (n=6) SARS-CoV-infected animals using an
ANOVA-based analysis called LIMMA, 202 gene transcripts
were differentially expressed (fold change $2; p,0.05; Table S1).
Upon analysis of these gene transcripts within the context of
biological processes and pathways using Ingenuity Pathways
Knowledge Base, this subset of genes showed indications for an
innate host response to viral infection. Among the top significantly
differentially regulated (p,0.005) functional categories were
immune response, inflammatory response and hematological
system development and function, which included genes like F3,
IL1RL1, IL1RN, IL6, IL8, S100A8, SERPINA1, SERPINA3, NP,
ACPP, TFPI2, SPP1, IGF1, EDN3, DEFB1, and SOCS3 (Figure 5A)
most of which were upregulated in SARS-CoV-infected aged
animals compared to young adult infected animals. In addition,
three of the most significantly regulated molecular/cellular
functions (p,0.005) were associated with a pro-inflammatory
response and included cell death, cell movement, and cell-to-cell
signalling (Figure 5A). The top gene interaction network, showing
the interplay between genes during the host response to viral
infection, contained NF-kB as central node (Figure 5B). NF-kBi sa
redox-sensitive transcription factor implicated to play a major role
in pro-inflammatory host responses and the development of ALI/
ARDS [24,25]. Several of the 202 differentially expressed gene
transcripts, among which IL1RN, SERPINA1, IL8, F3 and TFPI2,
are target genes for NF-kB. Thus, significant differences exist in
the host response to SARS-CoV infection, corresponding with age.
Figure 3. Viral replication levels in SARS-CoV-infected aged
and young adult macaques are similar. (A–B) SARS-CoV replication
in the throat (A) and nose (B) of SARS-CoV infected aged (black bars)
and young adult (white bars) macaques at day 2 and 4 post infection as
determined by real-time RT-PCR. Viral RNA levels are displayed as
TCID50 equivalents (eq.)/ml swab medium (6s.e.m.). (C) Average fold
change in SARS-CoV mRNA levels (6s.e.m.) in the lungs of aged and
young adult macaques compared to PBS-infected animals as deter-
mined by real-time RT-PCR and depicted on a log-scale. (D) Lung
sections of SARS-CoV-infected aged and young adult macaques were
stained with a mouse-anti-SARS-nucleocapsid IgG2a. Sections were
counterstained with hematoxylin. Original magnifications are 620.
doi:10.1371/journal.ppat.1000756.g003
Figure 4. Global gene expression profiles of individual young
adult and aged animals. Global gene expression profiles of normalized
log-2 based hybridization signals of individual young adult and aged
macaques of a set of gene transcripts that were identified as being
differentially regulated (fold change $2; FDR,0.05) in at least one of the
comparisons ofgeneexpression in the lungs ofexperimentally SARS-CoV-
infected aged and young adult macaques versus gene expression in the
lungs of PBS-infected macaques, and genes were included if they met the
criteria of an absolute fold change of $2-fold (FDR,0.05) in at least one
experiment. The data were plotted as a heat map, where each matrix
entry represents a gene expression value. Normalized log-2 based
hybridization signals ranged from 3 (green) to 14 (red). Dendograms
(trees) of the heat map represent the degree of relatedness between the
samples, with short branches denoting a high degree of similarity and
long branches denoting a low degree of similarity.
doi:10.1371/journal.ppat.1000756.g004
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infection, global gene expression profiles were determined in lungs
of SARS-CoV-infected aged (n=6) or young adult (n=6)
macaques in comparison to aged or young adult PBS-infected
macaques (n=4), respectively. Aged macaques differentially
expressed 1577 gene transcripts (Figure 6A). Gene ontology
analysis revealed that the majority of genes in the aged macaque
group compared to aged PBS-infected animals were associated
with a pro-inflammatory response and included cellular growth
and proliferation, cell death, cell movement, and cell-to-cell
signalling (Figure 6B). Although SARS-CoV-infected young adult
macaques differentially expressed much less gene transcripts
compared to young adult PBS-infected animals (Figure 6A), the
most significantly regulated molecular/cellular functions also
included cellular growth and proliferation, cell death, cell
movement, and cell-to-cell signalling (Figure 6B). This suggested
that the nature of the host response to infection in aged and young
adult animals was strikingly similar, even though the severity was
different.
Because the above described gene ontology molecular/cellular
functions are very broad, genes were further subdivided based on
available annotations to gain insight in differences in the host
response to infection in aged and young adult macaques compared
to aged and young adult PBS-infected animals, respectively. Heat
maps were generated for differentially regulated genes with
pro-inflammatory functions such as cell adhesion (Figure 6C),
apoptosis (Figure 6D), and cytokine/chemokine signalling
(Figure 6E). The greater number of differentially expressed genes,
as well as the brighter intensities (fold changes in transcripts)
included in the heat map for aged macaques, suggested that aged
macaques show a more zealous response to virus infection than
young adult macaques. This assumption was corroborated using
Goeman’s global test [26] on the defined gene subsets cell
adhesion, cytokine/chemokine signalling, and apoptosis. When
macaques were grouped according to severity of pathology instead
of age and compared to their respective PBS-infected controls,
increased numbers of differentially expressed gene transcripts and
increased fold changes for differentially expressed genes in
inflammatory pathways correlated positively with gross pathology
scores as well (Figure S4). Our data show that the innate host
response to SARS-CoV infection changes during aging in
macaques; age, pathology, and pro-inflammatory host response
go hand-in-hand.
In order to understand the host responses in the context of
senescence, we directly compared lung samples from PBS-infected
aged (n=4) and young adult (n=4) macaques. LIMMA analysis
revealed that 518 gene transcripts were differentially expressed
(fold change $2; p,0.05), with categories such as immunological
disease, haematological system and development, cell death, cell
movement, and cellular growth and proliferation among the top
significantly differentially regulated functions (p,0.005). Only 14
out of the 518 differentially expressed gene transcripts were also
differentially expressed in the direct contrast of SARS-CoV-
infected aged and young adult macaques. Our data indicate that
significant differences exist in the basal gene expression levels of
aged and young adult macaques, which may partly explain why
differences in pathology were observed after SARS-CoV infection.
NF-kB signalling in SARS-CoV-infected macaques
As NF-kB target genes were differentially regulated in the direct
comparison of SARS-CoV-infected aged and young adult
macaques (Figure 5), we focussed on NF-kB in the indirect
comparison of aged and young adult SARS-CoV-infected
macaques compared to aged and young adult PBS-infected
animals, respectively. A gene interaction network, showing the
interplay between ‘‘immune response’’-type genes with NF-kBa s
central node, revealed that aged SARS-CoV-infected macaques
Figure 5. Direct comparison of gene expression profiles in the
lungs of aged and young adult SARS-CoV-infected macaques.
(A) Number of differentially expressed genes in the direct contrast of
aged and young adult SARS-CoV-infected macaques with functions in
immune response, inflammatory response, hematological system
development and function, cell movement, cell death, or cell-to-cell
signaling and interaction obtained from Ingenuity Pathways Knowledge
Base. (B) This diagram shows a gene interaction network from Ingenuity
Pathways Knowledge Base with genes that are differentially expressed
in the contrast of aged and young adult SARS-CoV-infected animals.
The central node is NF-kB, a key transcription factor in inflammation
and ARDS. Genes depicted in green are downregulated and in red
upregulated.
doi:10.1371/journal.ppat.1000756.g005
Host Response to SARS-CoV
PLoS Pathogens | www.plospathogens.org 5 February 2010 | Volume 6 | Issue 2 | e1000756Figure 6. Aged macaques display a stronger host response to SARS-CoV infection than young adults. (A) Number of differentially
expressed gene transcripts in aged and young adult SARS-CoV-infected macaques compared to aged and young adult PBS-infected animals,
respectively ($2-fold change, FDR,0.05, LIMMA analysis). (B) Number of differentially expressed genes in aged and young adult macaque groups
compared to aged and young adult PBS-infected animals, respectively, with functions in cellular growth and proliferation, cell movement, cell death,
or cell-to-cell signaling and interaction obtained from Ingenuity Pathways Knowledge Base. White bars for young adult and black bars for aged
macaques. When SARS-CoV-infected aged and young adult macaques were compared directly, these cellular functions were significantly differentially
expressed as well. (C–E) Gene expression profiles showing differentially expressed genes coding for proteins involved in cell adhesion (C), apopotosis
(D), and cytokine/chemokine signalling (E) of aged and young adult macaques. Gene sets were obtained from Ingenuity Pathways Knowledge Base
and changed $2-fold in at least one of the macaque groups as compared to PBS-infected controls. The data presented are error-weighted fold
change averages for six young adult and aged animals. Genes shown in red were upregulated, in green downregulated, and in grey not significantly
diferentially expressed in infected animals relative to PBS-infected animals (log (base 2) transformed expression values with minimum and maximum
values of the color range being 24 and 4). Global test analysis of the direct contrast of SARS-CoV-infected aged versus young adult animals showed
that these pathways were significantly differentially expressed (P,0.05). See Table S2 and S3 for full gene names and expression values.
doi:10.1371/journal.ppat.1000756.g006
Host Response to SARS-CoV
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adult infected animals (Figure 7A) compared to their respective
PBS-infected animals, which was corroborated by an analysis of
differentially expressed target genes of NF-kB (Figure 7B). Several
of these genes, among which VCAM1, F3, PTX3, and IL-8, have
also been implicated in development of ARDS (Figure 7C)
[9,27,28].
In order to visualize NF-kB-signalling in the lungs of SARS-
CoV-infected aged and young adult macaques, translocation of
NF-kB was studied using immunohistochemistry with antibodies
Figure 7. NF-kB-signalling in aged and young adult macaques. (A) These diagrams show a gene interaction network from Ingenuity Pathways
Knowledge Base with genes that are differentially expressed in the contrast of aged SARS-CoV-infected animals versus aged PBS-infected macaques.
The central node is NF-kB, a key factor in inflammation and development of ARDS. Genes depicted in green are downregulated and in red
upregulated. As a reference, the same network is shown for young adult animals (left panel) and aged animals (right panel). (B–C) Gene expression
profiles showing differentially expressed NF-kB target genes (B) and genes coding for proteins involved ARDS (C) of aged and young adult macaques.
Gene sets were obtained from Ingenuity Pathways Knowledge Base or literature and changed $2-fold in at least one of the macaque groups as
compared to PBS-infected controls. The data presented are error-weighted fold change averages for six young adult and aged animals. Genes shown
in red were upregulated, in green downregulated, and in grey not significantly diferentially expressed in infected animals relative to PBS-infected
animals (log (base 2) transformed expression values with minimum and maximum values of the color range being 24 and 4). See Table S2 and S3 for
full gene names and expression values. (D) Lung sections of PBS and SARS-CoV-infected aged and young adult macaques were stained with an
antibody against phosphorylated NF-kB (brown) and with a mouse-anti-SARS-nucleocapsid IgG2a (red). Sections were counterstained with
hematoxylin. Original magnifications are 640.
doi:10.1371/journal.ppat.1000756.g007
Host Response to SARS-CoV
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in Figure 7D, hardly any phosphorylated NF-kB could be detected
in the nuclei of cells of PBS-infected macaques, while in the lungs
of SARS-CoV-infected animals, cells with phosphorylated NF-kB
in their nuclei were abundantly present. Phosphorylated NF-kB
was detected primarily in the nuclei of non-infected cells
(Figure 7D). No obvious differences in the translocation of NF-
kB in the lungs of aged and young adult macaques were observed.
Type I interferon-b mRNA level is negatively correlated
with gross pathology
Overall, our data indicate that SARS-CoV-infected aged
macaques display a stronger pro-inflammatory host response to
infection than young adult macaques. For example, mRNA levels
for IL8, a key player in ALI/ARDS and a potent chemotactic
factor essential in acute inflammation that is induced by a wide
range of stimuli among which IL1b, viral products, and oxidative
stress, were strongly upregulated in SARS-CoV-infected aged
macaques as compared to young adult animals (Figure 5B, 7B,
8A). Despite the overall stronger activation of innate host gene
responses in SARS-CoV-infected aged animals, microarray
analyses revealed that IFN-b, well-known for its antiviral activities,
was not differentially expressed in aged macaques compared to
PBS-infected animals, in contrast to young adults (Figure 6E). RT-
PCR analysis confirmed differential expression of IFN-b mRNA
between young adult and aged macaques (Figure 8B). As shown in
Figure 3, this difference in IFN-b levels in aged and young adult
macaques did not affect viral replication efficiency. IFN-b mRNA
levels, however, negatively correlated with gross pathology
(Figure 8C).
Anti-inflammatory action of type I interferon mitigates
pathology in SARS-CoV-infected aged macaques
The observation of a reverse correlation of IFN-b and IL-8
mRNA levels with age after SARS-CoV infection may reflect a
physiological cross-regulation in which type I interferon and/or its
respective signalling pathways modulate pro-inflammatory host
responses [29,30]. To corroborate this hypothesis, we treated
uninfected human PBMC with IL-1b, which is known to rapidly
activate NF-kB-signalling [31,32], and observed the induction of
pro-inflammatory cytokines in uninfected human PBMC, such as
IL-1b and IL-8 (Figure 8A–B). An anti-inflammatory effect of
pegylated IFN-a on IL-1b-induced responses was confirmed in
vitro, as a dose-dependent inhibition of IFN-a on recombinant IL-
1b-induced IL-1b and IL-8 mRNA levels in human PBMC was
observed (Figure 9A–B).
Because type I IFNs can inhibit pro-inflammatory signalling
pathways, among which NF-kB signalling pathways [29,30], we
examined whether exogenous administration of type I IFN in
SARS-CoV-infected aged macaques could influence SARS-CoV
pathogenesis. Retrospective analyses of the lungs of SARS-CoV-
infected aged animals treated therapeutically with type I IFN [22]
showed that SARS-CoV-infected IFN-treated aged animals
remained free of clinical symptoms and had no or less exten-
sive pulmonary consolidation than untreated aged macaques
(Figure 10A). Virus titers in the lungs, however, were similar
between IFN-treated and untreated aged macaques (Figure 10B)
and viral antigen expression in the lungs was not significantly
different [22].
In a direct comparison of the host response to infection in aged
(n=6) versus IFN-treated aged (n=3) macaques using LIMMA,
961 gene transcripts were differentially expressed (fold change $2;
p,0.05). Upon analysis of these gene transcripts within the context
of genetic pathways, four of the most significantly regulated
molecular/cellular functions (p,0.005) were associated with a
pro-inflammatory response and included cellular growth and
Figure 8. Quantitative RT-PCR confirmation of IFN-b mRNA
levels. (A) Quantitative RT-PCR for IL-8 was performed on two-three
separate lung samples per animal with substantial virus replication. The
data presented are error-weighted (6s.e.m.) averages of the fold-
change as compared to PBS-infected controls for young adult (n=6)
and aged (n=6) animals. (B) Quantitative RT-PCR for IFN-b was
performed on two-three separate lung samples per animal with
substantial virus replication. The data presented are error-weighted
(6s.e.m.) averages of the fold-change as compared to PBS-infected
controls for young adult (n=6) and aged (n=6) animals. (C) The
expression level of IFN-b (fold change) per animal was plotted against
gross pathology score and the correlation coefficient was determined
using Spearman’s correlation test.
doi:10.1371/journal.ppat.1000756.g008
Host Response to SARS-CoV
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pro-inflammatory cytokine production in PBMCs. (A–B) Induction
ofIL-1b (A)andIL-8 (B)mRNAsaftertreatment ofhumanPBMC withIL-1b
(5 ng/ml), IFN-a (1000 U/ml, 100U/ml, or 10 U/ml) or both as determined
by quantitative RT-PCR. The data presented are error-weighted (6s.e.m.)
averages of the fold-change as compared to untreated (Mock) PBMC.
Shown are representative data from one out of four donors.
doi:10.1371/journal.ppat.1000756.g009
Figure 10. Anti-inflammatory type I IFN inhibits virus-induced
ALI in aged SARS-CoV-infected macaques. (A) Gross pathology
scores of lungs from macaques were determined during necropsy and
averaged (6s.e.m.). (B) Average fold change (6s.e.m.) in SARS-CoV
mRNA levels in the lungs of pegylated IFN-a-treated (n=3) and
untreated aged (n=6) macaques compared to aged PBS-infected (n=4)
animals as determined by real-time RT-PCR. (C) Number of differentially
expressed gene transcripts compared to aged PBS-infected animals
($2-fold change). (D) Quantitative RT-PCR for IL-8 was performed on
two-three separate lung samples per animal with substantial virus
replication. The data presented are error-weighted (6s.e.m.) averages
of the fold-change as compared to PBS-infected controls for aged
animals (n=6) and aged animals treated with IFN-a (n=3).
doi:10.1371/journal.ppat.1000756.g010
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indicating that significant differences exist in the host response to
SARS-CoV infection in animals treated with type I IFN compared
to untreated aged macaques.
To obtain a broader view of the host response to infection,
global gene expression profiles were determined in lungs of SARS-
CoV-infected aged (n=6) or IFN-treated aged macaques (n=3)in
comparison to aged PBS-infected macaques (n=4). IFN-treated
macaques differentially expressed (fold change $2; p,0.05)
approximately four-fold less gene transcripts than untreated aged
macaques (Figure 10C) as compared to PBS-infected animals. The
most significantly regulated molecular/cellular functions in the
IFN-treated macaque group compared to PBS-infected animals
were associated with a pro-inflammatory response and included
cellular growth and proliferation, cell death, cell movement, and
cell-to-cell signalling, similar to what was observed for the aged
macaque group, although less genes per function were differen-
tially expressed (Figure S5A). These data suggested a common
nature of the host response to infection in aged and IFN-treated
aged animals, although the severity seemed different.
To gain more insight in differences in the host response to
infection in aged and IFN-treated macaques compared to PBS-
infected animals, heat maps were generated for differentially
regulated genes involved in pro-inflammatory pathways apoptosis
(Figure S5B) and cell adhesion (Figure S5C). Using Goeman’s
global test [26] on the defined gene subsets cell adhesion and
apoptosis, significant differences between aged and IFN-treated
animals in these pro-inflammatory pathways were obtained,
providing statistical evidence for a difference in host response of
aged and IFN-treated animals to SARS-CoV infection. Moreover,
a decrease in differentially expressed target genes of NF-kB was
observed (Figure S5D). Most notably, a dramatic decrease in the
expression of cytokine/chemokine mRNA levels was observed,
among which IL-8 (Figure 10D, Figure S5B–C). These data show
that therapeutic treatment of SARS-CoV-infected aged macaques
with type I IFN primarily results in downregulation of pro-
inflammatory host responses.
Discussion
Age, pathology and pro-inflammatory host response go
hand-in-hand
The present study aimed at gaining insight into the pathogenesis
of SARS-CoV by studying the relationship between age,
pathology, virus replication, and host response in a macaque
model. In humans, SARS-CoV infection progresses from an
atypical pneumonia to acute diffuse alveolar damage and ARDS
[5]. The overall human fatality rate reached ,10% and up to 50%
in elderly [5,6]. The acute lung injury observed after SARS-CoV
infection in aged macaques is similar to what has been seen in
humans that progress to ARDS [6]. This disease process includes
an acute exudative phase, consisting of severe leukocyte infiltra-
tion, edema, the formation of hyaline membranes, and prolifer-
ation characterized by type II pneumocyte hyperplasia [33].
SARS-CoV-infected aged macaques develop more severe pathol-
ogy than young adult animals, even though viral replication levels
are similar. The chronic phase, which is characterized by
persistent intra-alveolar and interstitial fibrosis and mortality was
not observed because animals were sacrificed early after infection.
Comparative analyses of gene expression in aged and young
adult SARS-CoV-infected macaques revealed that the host
response to SARS-CoV infection is similar in nature, but differs
significantly in severity in pro-inflammatory responses. Aged
macaques had a stronger host response to virus infection than
young adult macaques, with an increase in differential expression
of genes associated with inflammation that center around the
transcription factor NF-kB. Comparative analysis of PBS-infected
aged and young adult macaques revealed significant differences in
gene expression as a result of aging only. These observations are in
line with earlier hypotheses that age-related accumulated oxidative
damage and a weakened antioxidative defense system cause a
disturbance in the redox balance, resulting in increased reactive
oxygen species. Subsequently, the oxidative stress-induced redox
imbalance activates redox-sensitive transcription factors, such as
NF-kB, followed by the induction of pro-inflammatory genes
including IL1b, IL6, TNFa and adhesion molecules, key players in
the inflammatory process [34]. Oxidative stress may also
potentiate the cellular responses to IL-1b [35], an early mediator
of inflammation [36]. Thus, aging is associated not only with
alterations in the adaptive immune responses, but also with a pro-
inflammatory state in the host [34,37,38,39]. Oxidative stress and
toll-like receptor-4 signaling via NF-kB triggered by viral lung
pathogens, such as SARS-CoV, may further amplify the host
response ultimately resulting in ALI [25]. Taking the host gene
expression profiles of PBS-infected aged and young adult
macaques into account, we also observed a stronger activation of
the pro-inflammatory pathways in SARS-CoV-infected aged
macaques than in young adults. The finding that genes activated
by NF-kB are significantly differentially upregulated in aged
macaques infected with SARS-CoV is in line with the role of NF-
kB as a redox-sensitive transcription factor in pro-inflammatory
host responses and the development of ALI/ARDS [24,25]. Given
the fact that several SARS-CoV proteins block NF-kB signaling
[40,41,42], we hypothesize that NF-kB-signaling in non-infected
cells is largely responsible for the upregulated expression of NF-kB
target genes, such as IL8, in aged compared to young adult
macaques.
These observations are largely in line with transcriptome
analyses in mice and SARS patients. In severe SARS patients,
cytokines/chemokine involvement as the illness progresses may
lead to widespread immune dysregulation and serious pathogenic
events [13]. Aged mice show more pathology than young adult
mice and the transcriptional profile in aged mice generally
indicates a more robust pro-inflammatory response to virus
infection than in young mice [43,44].
Type I IFN signalling
Previously, we demonstrated IFN induction and signalling in
SARS-CoV-infected macaques early after infection [19]. Based on
the observation that plasmacytoid dendritic cells are able to
produce type I IFNs after SARS-CoV infection in vitro [45], it was
speculated that these cells are the IFN-producing cells in lungs of
SARS-CoV-infected macaques. In addition, phosphorylated
STAT-1 was observed in the nuclei of numerous cells in the
lungs of SARS-CoV-infected macaques, indicating that these cells
had been activated by IFNs or other agonists produced in the lung
[19]. In SARS-CoV-infected cells, however, STAT-1 signalling
was blocked [19], consistent with the fact that a range of SARS-
CoV proteins can function as interferon antagonists that inhibit
IFN production and signalling [41,42]. Therefore, a large part of
the genes activated downstream of STAT-1, observed in genomics
analyses, is likely due to signalling in non-infected cells [19]. In the
current study, we observed that aged macaques expressed
significantly lower levels of IFN-b mRNA than young adult
macaques and that IFN-b mRNA levels correlated negatively with
severity of pathology. Interestingly, aged and young adult SARS-
CoV-infected macaques showed opposite expression patterns for
type I IFN-b and certain pro-inflammatory cytokines, such as
Host Response to SARS-CoV
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showing that higher amounts of pro-inflammatory cytokines, such
as IL-1b and IL-8, are produced upon stimulation of leukocytes of
the elderly, whereas induction of type I IFNs is decreased
compared to young adults [46,47,48].
Cross-regulation between type I IFN and NF-kB signalling
cascades
The observation of a reverse correlation of IFN-b and IL-8
mRNA levels with age after SARS-CoV infection may reflect a
physiological cross-regulation between antiviral STAT-1 and
proinflammatory NF-kB pathways. Evidence for such a cross-
regulation between type I IFN/STAT-1 and pro-inflammatory/
NF-kB signaling pathways exists. Type I interferons exert sig-
nificant anti-inflammatory effects and provide at least partial
protection from disease in collagen-induced arthritis, auto-
immune encephalitis, and multiple sclerosis [49,50,51,52,53].
Not only inhibits IFN-beta expression of the IL8 gene at the
transcriptional level [54], type I IFNs can also activate TAM
receptor tyrosine kinases that inhibit toll-like receptor-induced
cytokine-receptor cascades [55,56] and induce the immunosup-
presive cytokine IL-10 [57]. Direct NF-kB/STAT-1 protein-
protein interactions [58] and modification of STAT-1 by
acetylation, may be involved in this process [30]. A loss of type I
IFN/STAT-1 signaling in aged macaques may negatively regulate
interferon-induced gene expression and type I IFN signaling,
which may lead to enhanced inflammatory responses. On the
other hand, increased activation of NF-kB signaling pathways in
aged macaques may negatively regulate interferon-induced gene
expression and type I IFN signaling [29,59,60], which may
enhance pro-inflammatory responses even further.
We have integrated our data and other findings on cross-
regulation in a model (Figure 11). The model depicts the innate
immune response to SARS-CoV infection as a coordinated series of
signaling pathways aimed at clearing the virus while not harming
host cells. Upon SARS-CoV infection, infected cells, depicted in the
model as pneumocytes, produce inflammatory mediators that
activate NF-kB, resulting in the production of pro-inflammatory
cytokines and chemokines, such as IL-8. IL-1 is one of the cytokines
highly upregulated on day 1 after infection upon SARS-CoV
infection of macaques [19] and capable of activating NF-kB. At the
same time, the virus is recognized by sentinel cells, such as pDCs,
that produce type I IFNs to signal that a foreign invader has entered
the host. The production of IFN induces neighboring non-infected
cells to remodel the intracellular environment by producing a range
of antiviral proteins, aiding in a block of viral replication. A cross-
regulation between the ‘‘antiviral’’ and ‘‘pro-inflammatory’’
pathways occurs, which is a critical requirement to allow fine-
tuning of the host response to infection and return to homeostasis.
Disease outcome may be determined by the relative contribution of
‘‘antiviral’’and ‘‘pro-inflammatory’’pathwaysandapparentlyaging
influences this intricate balance significantly.
Causal relationships between ‘‘antiviral’’ and ‘‘pro-inflammato-
ry’’ pathways in macaques are difficult to prove and future studies
in specific gene knock-out mice should therefore further clarify the
complex interactions in the response to SARS-CoV. Our own in
vitro experiments and the type I IFN intervention in SARS-CoV-
infected aged macaques indicate that type I IFNs can play a role in
mitigating pro-inflammatory host responses and severity of
pathology. Therapeutic treatment of SARS-CoV-infected aged
macaques with type I IFN reduces pathology and diminishes pro-
inflammatory gene expression, including IL-8 levels, without
affecting virus replication in the lungs. Antiviral effects of type I
IFNs were not obvious, probably due to the fact that SARS-CoV
infected cells inhibit STAT-1 signalling and viral replication peaks
early after infection when treatment with pegylated IFN-a started.
Given the fact that phosphorylated NF-kB was present mainly in
the nuclei of non-infected cells in the lungs of SARS-CoV-infected
macaques, these cells are potential targets for the action of IFN
and subsequent STAT-1 signalling. It remains uncertain whether
endogenously produced IFNs in young adult macaques are
essential in the control of inflammatory responses or that enhanced
activation of inflammatory pathways simply does not occur. Our
data are in line with the observation that treatment of SARS-CoV-
infected aged mice with type II IFN-c, which like type I IFN also
signals via STAT-1, protected against lethal respiratory illness,
seemingly without an effect on viral replication [61]. Moreover, in
humans with SARS, use of type I IFNs was associated with
reduced disease-associated hypoxia and a more rapid resolution of
radiographic lung abnormalities [62]. Whether the anti-inflam-
matory action of type I/II IFNs in macaques, mice and humans
occurs via common pathways and is interchangeable between host
species remains to be determined. Assuming that there is a
conserved pathway in ALI/ARDS induced by multiple pathogens,
including pandemic viruses that may emerge from avian influenza,
modulation of the host response by type I IFNs provides a
promising outlook for novel intervention strategies.
Figure 11. Model for cross-talk between ‘‘pro-inflammatory’’
and ‘‘antiviral’’ pathways during SARS-CoV infection. SARS-CoV
infection results in activation of both ‘‘antiviral’’ and ‘‘pro-inflammatory’’
pathways. Subsets of uninfected cells, depicted by pDCs, start
producing type I IFN (IFN-a), which results in STAT-1 activation in
neighbouring cells, which in turn may produce other mediators (e.g.
IFN-b). The SARS-CoV-infected cells produce inflammatory mediators,
supposedly IL-1, which results in NF-kB activation in neighbouring
uninfected cells and subsequent production of inflammatory mediators,
such as IL-8. Cross-regulation between ‘‘antiviral’’ and ‘‘pro-inflamma-
tory’’ pathways allows polarisation of antiviral or pro-inflammatory
responses thereby modulating pathology. Modulation of transcription
factors in the uninfected cells, e.g. by aging, may affect the overall
outcome of the infection.
doi:10.1371/journal.ppat.1000756.g011
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Macaque studies
Six young adult cynomolgus macaques (Macaca fascicularis), 3–5
years old, four of which carried active temperature transponders in
the peritoneal cavity, and four aged cynomolgus macaques, 10–18
years old, which all carried active temperature transponders, were
inoculated with SARS-CoV strain HKU39849, as described
previously [19,21,22,23]. Two additional aged animals (17 and
19 years old), previously infected with SARS-CoV strain
HKU39849 [22], were enrolled in this study as well. Four young
adult mock (PBS) infected animals from a previous study [19] and
four aged macaques were taken as controls. Lung tissues stored
in RNA-later from three cynomolgus macaques, 13 years old,
previously inoculated with SARS-CoV strain HKU39849 and
treated with pegylated IFN-a at a dose of 3 mg/kg intramuscularly
on days 1 and 3 after infection, were taken along for molecular
analyses [22]. All animals were infected with the same dose of
virus, using the same inoculation procedure, by the same person to
minimize inter-experiment variation. All animals were checked
daily for clinical signs and anaesthetised with ketamine on days 0,
2 and 4 after infection to collect oral, nasal, and rectal swabs [22].
All animals were euthanized on day 4 post infection. Necropsies
and sampling for histology/immunohistochemistry were per-
formed as described [22]. The percentage of affected lung tissue
from each lung lobe was determined at necropsy, recorded on a
schematic diagram of the lung and the area of affected lung tissue
was subsequently calculated (gross pathology score).
Ethics
Approval for animal experiments was obtained from the
Institutional Animal Welfare Committee and performed according
to Dutch guidelines for animal experimentation.
Immunohistochemistry
Serial 3 mm lung sections were stained using mouse-anti-SARS-
nucleocapsid IgG2a (clone Ncap4; Imgenex) 1:1600, mouse-anti-
human neutrophil elastase (clone NP-57; DAKO) 1:10, mouse-
anti-human CD68 (clone KP1; DAKO) 1:200, mouse-anti-human
pankeratin (clone AE1/AE3; Neomarkers) 1:100, rabbit anti p-
NF-kB p65 (Santa Cruz) or rabbit control and isotype antibodies
(clones 11711 and 20102; R&D), according to standard protocols
[22,23]. Quantitative assessment of SARS-CoV infection in the
lungs was performed as described previously [22].
RNA-extraction and quantitative RT-PCR
RNA from 200 ml of swabs was isolated with the Magnapure
LC total nucleic acid isolation kit (Roche) external lysis protocol
and eluted in 100 ml. SARS-CoV RNA was quantified on the ABI
prism 7700, with use of the Taqman Reverse Transcription
Reagents and Taqman PCR Core Reagent kit (Applied
Biosystems), using 20 ml isolated RNA, 16 Taqman buffer,
5.5 mM MgCl2, 1.2 mM dNTPs, 0.25 U Amplitaq gold DNA
polymerase, 0.25 U Multiscribe reverse transcriptase, 0.4 U
RNAse-inhibitor, 200 nM primers, and 100 nM probe [23].
Amplification parameters were 30 min at 48uC, 10 min at 95uC,
and 40 cycles of 15 s at 95uC, and 1 min at 60uC. RNA dilutions
isolated from a SARS-CoV stock were used as a standard. Average
results (6s.e.m.) for young adult (n=6) and aged macaque (n=4)
groups were expressed as SARS-CoV equivalents per ml swab
medium.
Lung tissue samples (0.3–0.5 gram) were taken for RT-PCR and
microarray analysis in RNA-later (Ambion, Inc.). RNA was
isolated from homogenized post mortem tissue samples using
Trizol Reagent (Invitrogen) and the RNeasy mini kit (Qiagen).
cDNA synthesis was performed with 1 mg total RNA and
Superscript III RT (Invitrogen) with oligo(dT), according to the
manufacturer’s instructions. Semi-quantitative RT-PCR was
performed to detect SARS-CoV mRNA and to validate cellular
gene expression changes as detected with microarrays [19].
Differences in gene expression are represented as the fold change
in gene expression relative to a calibrator and normalized to a
reference, using the 2
2DDCt method [63]. GAPDH (glyceralde-
hydes-3-phosphate dehydrogenase) was used as endogenous
control to normalize quantification of the target gene. The
samples from the young adult PBS-infected macaques were used as
a calibrator. Average results (6s.e.m.) for young adult (n=6), aged
(n=6), and IFN-a-treated aged (n=3) macaque groups were
expressed as fold change compared to young adult PBS-infected
animals, respectively [63]. In addition, groups were based on
severity of pathology: young adult macaques (n=6), aged
macaques with pathology (n=4), and aged macaques with severe
pathology with .40% of lungs affected (n=2) (Supplementary
Figure 4). As titration of lung homogenates gave inconsistent
results in our hands and because the effects of endogenous and
exogenous IFN may influence titration outcomes, we chose
taqman and immunohistochemistry to determine viral replication
levels in the lung.
Isolation and activation of PBMC
PBMC from healthy blood donors were isolated from
heparinized venous blood using Lymphoprep (Axis-Shield).
PBMC were resuspended at 2610
6/ml in RPMI 1640 medium
(Biowhittaker) supplemented with L-glutamine (2 mM), penicillin
(100 U/ml), streptomycin (100 mg/ml), and 10% fetal calf serum.
Freshly isolated PBMC were incubated with IL-1b (5 ng/ml;
eBioscience), IFN-a 2a (1000 U/ml, 100U/ml, or 10U/ml;
Roferon-A; Roche) or both for 24 hours in duplo or triplo per
donor. Total RNA from stimulated PBMC was isolated using
Trizol Reagent (Invitrogen) and the RNeasy mini kit (Qiagen).
cDNA synthesis was performed with 100 ng total RNA and
Superscript III RT (Invitrogen) with oligo(dT), according to the
manufacturer’s instructions. Semi-quantitative RT-PCR was
performed for IL-8 [19] and IL-1b (Taqman gene expression
assays; Applied Biosystems) as described previously using the
2
2DDCt method [63]. Average results (6s.e.m.) were expressed as
fold change compared to untreated (mock) cells [63].
Statistical analysis
Data (RT-PCR and gross pathology scores for SARS-CoV-
infected young adult versus aged and aged versus aged animals
treated with IFN) were compared using Student’s t-test with
Welch’s correction. Differences were considered significant at
P,0.05. One-way ANOVA and Bonferroni’s multiple comparison
test were used for the comparison of data in groups based on
severity of pathology (low, medium, high) and in vitro IFN
inhibition experiments. Correlation coefficients were determined
using Spearman’s correlation test.
RNA labeling, microarray hybridization, scanning and
data preprocessing
Pooled total RNA (2.4 mg) from one-three separate lung pieces of
all animals (including previously infected animals), with substantial
SARS-CoV replication (.10
5 fold change), was labeled using the
One-Cycle Target Labeling Assay (Affymetrix) and hybridized onto
Affymetrix GeneChip Rhesus Macaque Genome Arrays (Affyme-
trix), according to the manufacturer’s recommendations. Image
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(Affymetrix). Microarray Suite version 5.0 software (Affymetrix) was
used to generate .dat and .cel files for each experiment. All data
were normalized using a variance stabilization algorithm (VSN)
[64]. Transformed probe values were summarized into one value
per probe set by the median polish method [65]. Primary data is
available at http://www.virgo.nl in accordance with proposed
MIAME standards.
Microarray data analysis
Probe set (gene) wise comparisons between the experimental
conditions (aged, young adult and IFN-treated animals versus
young adult or aged PBS-infected animals and directly compared to
each other) were performed by LIMMA (version 2.12.0) [66].
Correction for multiple testing was achieved by requiring a false
discovery rate (FDR) of 0.05, calculated with the Benjamini-
Hochberg procedure [67]. To understand the gene functions and
the biological processes represented in the data and obtain
differentially expressed molecular and cellular functions, Ingenuity
Pathways Knowledge Base (http://www.ingenuity.com/) was used.
Heat maps of pro-inflammatory pathways were produced using
complete linkage and Euclidian distance in Spotfire DecisionSite for
Functional Genomics version 9.1 (http://www.spotfire.com/) and
Ingenuity Pathways Knowledge Base (http://www.ingenuity.com/),
using log (base 2) transformed expression values with minimum and
maximum values of the color range being 24 and 4, respectively.
Differences between conditions in expression of specific pro-
inflammatory pathways, e.g. direct comparison of defined gene sets
(aged versus young adult and aged versus aged IFN-treated animals),
were tested by Goeman’s global test procedure [26]. Hierarchical
clustering analysis of normalized log-2 based hybridization signals of
individual young adult and aged macaques of a set of gene transcripts
that were identified as being differentially regulated (fold change $2;
FDR,0.05) in at least one of the comparisons of young adult versus
young adultPBS or aged versus aged PBS animals were created using
Spotfire DecisionSite for Functional Genomics version 9.1 (http://
www.spotfire.com/) with complete linkage and Eucledian distance
parameters.
Supporting Information
Table S1 Annotated differentially expressed genes in aged versus
young adult SARS-CoV infected macaques.
Found at: doi:10.1371/journal.ppat.1000756.s001 (0.15 MB
DOC)
Table S2 Description of genes
Found at: doi:10.1371/journal.ppat.1000756.s002 (0.04 MB
DOC)
Table S3 Log (base 2)-transformed expression values of genes in
the heat maps in Fig 6, Fig. 7, and Fig. S5.
Found at: doi:10.1371/journal.ppat.1000756.s003 (0.03 MB
DOC)
Table S4 Log (base 2)-transformed expression values of genes in
heat maps in Fig. S4
Found at: doi:10.1371/journal.ppat.1000756.s004 (0.03 MB
DOC)
Figure S1 Gross lesions in aged macaque. (A) SARS-CoV-
induced lesions (white arrows) in the lung are still visible after
inflation with 10% neutral-buffered formalin. (B–C) Schematic
diagrams of the lungs showing gross pathology lesions of SARS-
CoV-infected young adult (B) and aged (C) macaques.
Found at: doi:10.1371/journal.ppat.1000756.s005 (0.31 MB PDF)
Figure S2 Histology and immunohistochemical detection of cells
in lungs from SARS-CoV-infected macaques. (A–B) Lesion in the
lung of a SARS-CoV-infected aged macaque, characterized by
thickened alveolar walls lined by type II pneumocytes (type II
pneumocyte hyperplasia) with influx of inflammatory cells.
Consecutive sections were stained with a mouse monoclonal
anti-human CD68 antibody for macrophages (A) and a mouse
monoclonal anti-human neutrophil elastase antibody for neutro-
phils (B). Sections were counterstained with hematoxylin. (C)
Lesions in the lung of a SARS-CoV infected aged macaque
showing diffuse alveolar damage, characterized by type II
pneumocyte hyperplasia with influx of inflammatory cells. (D)
Lesion in the lung of a SARS-CoV-infected aged macaque,
characterized by thickened alveolar walls lined by type II
pneumocytes stained with a mouse monoclonal anti-human
pankeratin antibody for epithelial cells. (E–F) Hyaline membranes
(E) and syncytia (F) were occasionally observed in the lungs of aged
macaques. Original magnifications are 620 and 640.
Found at: doi:10.1371/journal.ppat.1000756.s006 (0.11 MB PDF)
Figure S3 Global gene expression profiles of individual young
adult and aged animals. For a subset of gene transcripts, cytokines
and chemokines, normalized log-2 based hybridization values for
individual aged and young adult macaques are shown.
Found at: doi:10.1371/journal.ppat.1000756.s007 (0.01 MB PDF)
Figure S4 Microarray analyses of the lower respiratory tract of
SARS-CoV-infected macaques displaying different levels of
severity of pathology. (A) Gross pathology scores of the lungs
from aged and young adult macaques were determined. Based on
the severity of pathology, macaques were divided in three groups
(low (young adult; n=6), medium (aged; n=4), and high (aged;
n=2) pathology score), and average pathology scores (6s.e.m.) are
shown. (B) Number of differentially expressed gene transcripts
compared to uninfected animals ($2-fold change) in macaque
groups. (C) Number of differentially expressed genes in macaque
groups compared to PBS-infected animals with functions in
cellular growth and proliferation, cell movement, cell death, or
cell-to-cell signaling and interaction obtained from Ingenuity
Pathways Knowledge Base. (D) Average fold change (6s.e.m.) in
SARS-CoV mRNA levels in the lungs of macaques with low,
medium and high pathology scores as compared to PBS-infected
animals as determined by real-time RT-PCR. (E–G) Gene
expression profiles showing differentially expressed genes coding
for proteins involved in cell adhesion (E), proteins involved in
apoptosis (F), and cytokines and chemokines (G) of macaque
groups with low, medium and high pathology scores as compared
to PBS-infected animals. Genes displayed were obtained from
Ingenuity Pathways Knowledge Base and changed $2-fold in at
least one of the macaque groups as compared to PBS-infected
controls. The data presented are error-weighted averages. Genes
shown in red were upregulated and in green downregulated in
infected animals relative to PBS-infected animals (log (base 2)
transformed expression values with minimim and maximum
values of the color range being 24 and 4). Genes shown in grey
were not significantly differentially regulated. See Table S2 and S4
for full gene names and expression values.
Found at: doi:10.1371/journal.ppat.1000756.s008 (0.05 MB PDF)
Figure S5 Microarray analyses of the lower respiratory tract of
SARS-CoV-infected aged and aged macaques treated with
pegylated IFN-a. (A) Number of differentially expressed genes in
macaque groups compared to PBS-infected animals with functions
in cell growth and proliferation, cell movement, cell death, or cell-
to-cell signaling and interaction obtained from Ingenuity Pathways
Knowledge Base. When SARS-CoV-infected aged macaques were
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were significantly differentially expressed. (B–D) Gene expression
profiles showing differentially expressed genes coding for proteins
involved in apoptosis (B), cell adhesion (C), or NF-kB-signaling (D)
of IFN-a-treated and untreated aged macaques. Genes displayed
were obtained from Ingenuity Pathways Knowledge Base or
literature and changed $2-fold in at least one of the groups as
compared to PBS-infected controls. The data presented are error-
weighted averages. Genes shown in red were upregulated, in green
downregulated, and in grey not significantly differentially
expressed in infected animals relative to PBS-infected animals
(log (base 2) transformed expression values with minimum and
maximum values of the color range being 24 and 4). Global test
analysis of the direct contrast of SARS-CoV-infected aged versus
IFN-treated aged animals showed that the cell adhesion and
apoptosis pathways were significantly differentially expressed
(p,0.05). See Table S2 and S3 for full gene names and expression
values.
Found at: doi:10.1371/journal.ppat.1000756.s009 (0.03 MB PDF)
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